Sociedade Brasileira de Hematologia e Hemoterapia
Sociedade Brasileira de Hematologia e Hemoterapia
 

  NOVOS SÓCIOS

Seja sócio da SBHH!
Faça o cadastro!
Faça seu cadastro!

  NAVEGADOR SBHH

Busca de Artigos Científicos
Controle de Qualidade Externo em Imuno-hematologia
Controle de Qualidade em Hemoterapia
HEMO 2007
Datas Comemorativas da Área da Saúde
Ética Médica
Legislação
Links
Publicações
Quem é Quem nos Hemocentros
Sala de Imprensa

SBHH Responde

Doação de Sangue
Onde, como e quem pode?

BRITISH JOURNAL OF HAEMATOLOGY - 138 (3) – 1ª quinzena Agosto 2007

British Journal of Haematology - 138 (3) - Agosto (1ª quinzena)

Images in Haematology
Detection of FIP1L1-PDGFRA fusion by FISH
Edmond S. K. Ma, K. F. Wong, Chris L. P. Wong and Lisa L. P. Siu
p. 279–279

Multisystem Erdheim-Chester disease; a unique presentation with liver and axial skeletal involvement
Arun Gupta, Kholoud Aman, Marwa Al-Babtain, Hanan Al-Wazzan and Rajja Morouf
p. 280–280

Reviews
Dendritic cells and myeloid leukaemias: plasticity and commitment in cell differentiation
Jane Rasaiyaah, Kwee Yong, David R. Katz, Paul Kellam and Benjamin M. Chain
p. 281–290

Modern treatment of thalassaemia intermedia
Caterina Borgna-Pignatti
p. 291–304

Inhibitor development in haemophilia B: an orphan disease in need of attention
Donna DiMichele
p. 305–315

Haematological Malignancy
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas
M. Ponzoni, F. Berger, C. Chassagne-Clement, M. Tinguely, A. Jouvet, A. J. M. Ferreri, S. Dell'Oro, M. R. Terreni, C. Doglioni, J. Weis, M. Cerati, M. Milani, P. Iuzzolino, T. Motta, A. Carbone, E. Pedrinis, J. Sanchez, J.-Y. Blay, M. Reni , A. Conconi, F. Bertoni, E. Zucca, F. Cavalli and B. Borisch on Behalf of the International Extranodal Lymphoma Study Group (IELSG)
p. 316–323
Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous P53 deletion and poor survival for multiple myeloma
Hong Chang, Joanna Yeung, Connie Qi and Wei Xu
p. 324–329

Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
Martin Kropff, Guido Bisping, Elke Schuck, Peter Liebisch, Nicola Lang, Markus Hentrich, Tobias Dechow, Nicolaus Kröger, Hans Salwender, Bernd Metzner, Orhan Sezer, Monika Engelhardt, Hans-Heinrich Wolf, Hermann Einsele, Sarah Volpert, Achim Heinecke, Wolfgang E. Berdel and Joachim Kienast, on behalf of the Deutsche Studiengruppe Multiples Myelom, DSMM
p. 330–337

Activation of Wnt/β-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia
Naveed I. Khan, Kenneth F. Bradstock and Linda J. Bendall
p. 338–348

Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals
Carsten Hirt, Gottfried Dölken, Siegfried Janz and Charles S. Rabkin
p. 349–353

Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation
Naseema Gangat, Jacob Strand, Chin-Yang Li, Wenting Wu, Animesh Pardanani and Ayalew Tefferi
p. 354–358

Platelets, Haemostasis and Thrombosis
Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency
Muriel Giansily-Blaizot, Delphine Thorel, Philippe Khau Van Kien, Catherine Behar, Marie-Catherine Romey, Francine Mugneret, Jean-François Schved and Mireille Claustres
p. 359–365

Thrombin generation: the functional role of alpha-2-macroglobulin and influence of developmental haemostasis
V. Ignjatovic, A. Greenway, R. Summerhayes and P. Monagle
p. 366–368

Haemopoiesis and Leucocytes
Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability
Alice Fabarius, Michelle Giehl, Oliver Frank, Birgit Spiess, Chun Zheng, Martin C. Müller, Christel Weiss, Peter Duesberg, Rüdiger Hehlmann, Andreas Hochhaus and Wolfgang Seifarth
p. 369–373

Red Cells and Iron
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator
Paul Harmatz, Robert W. Grady, Paul Dragsten, Elliott Vichinsky, Patricia Giardina, Jacqueline Madden, Michael Jeng, Becky Miller, Gregory Hanson and Bo Hedlund
p. 374–381

Expression of the γ-globin gene is sustained by the cAMP-dependent pathway in β-thalassaemia
Lakiea Bailey, Yuichi Kuroyanagi, Carla F. Franco-Penteado, Nicola Conran, Fernando F. Costa, Sabrina Ausenda, Maria D. Cappellini and Tohru Ikuta
p. 382–395

Correspondence
Unexpected cardiotoxicity in haematological bortezomib treated patients
Orciuolo Enrico, Buda Gabriele, Cecconi Nadia, Galimberti Sara, Versari Daniele, Cervetti Giulia, Salvetti Antonio, and Petrini Mario
p. 396–397

Hemizygous antithrombin-deficiency (Budapest III) in a newborn presenting with a thrombosis at birth
Søren Risom Kristensen, Marianne Käehne and Niels Erik Petersen
p. 397–398

Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes
Ulrich Germing, Uwe Platzbecker, Aristoteles Giagounidis and Carlo Aul
p. 399–400

Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism
Jose Luís Lobo, David Jiménez, Ma Teresa Orue, Enric Grau, Dolores Naufall, Olga Madridano, Manuel Monreal and the RIETE Investigators
p. 400–403


  Sociedade Brasileira de Hematologia e Hemoterapia
  Rua da Assembléia, nº 10 Grupo 1704 - Centro - Rio de Janeiro - RJ - Brasil - CEP 20011-901
  Tel/Fax: +55 (21) 3511-1101